Comparing the effects of antidepressants: Consensus guidelines for evaluating quantitative reviews of antidepressant efficacy

Jeffery A. Lieberman, Joel Greenhouse, Robert M. Hamer, K. Ranga Krishnan, Charles Nemeroff, David V. Sheehan, Michael E. Thase, Martin B. Keller

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

With increasing numbers of treatment options available for patients with major depression over the last decade and the growing body of evidence describing their efficacy and safety, clinicians often find it difficult to determine the best and most appropriate evidence-based treatment for each patient. Systematic reviews utilizing statistical methods that synthesize and evaluate data from a number of studies have become increasingly more available over the past decade. We review major findings and lessons learned from salient examples of quantitative analyses of antidepressant research and provide recommendations for meta-analysts, journal and grant reviewers, and research 'consumers' (ie, clinicians) for conducting, reporting, and evaluating such analyses.

Original languageEnglish
Pages (from-to)445-460
Number of pages16
JournalNeuropsychopharmacology
Volume30
Issue number3
DOIs
StatePublished - Mar 1 2005
Externally publishedYes

Fingerprint

Antidepressive Agents
Guidelines
Organized Financing
Research
Safety
Therapeutics

Keywords

  • Antidepressive agents
  • Evidence-based medicine
  • Meta-analysis
  • Quality control
  • Randomized controlled trials
  • Research design

ASJC Scopus subject areas

  • Pharmacology

Cite this

Comparing the effects of antidepressants : Consensus guidelines for evaluating quantitative reviews of antidepressant efficacy. / Lieberman, Jeffery A.; Greenhouse, Joel; Hamer, Robert M.; Krishnan, K. Ranga; Nemeroff, Charles; Sheehan, David V.; Thase, Michael E.; Keller, Martin B.

In: Neuropsychopharmacology, Vol. 30, No. 3, 01.03.2005, p. 445-460.

Research output: Contribution to journalArticle

Lieberman, Jeffery A. ; Greenhouse, Joel ; Hamer, Robert M. ; Krishnan, K. Ranga ; Nemeroff, Charles ; Sheehan, David V. ; Thase, Michael E. ; Keller, Martin B. / Comparing the effects of antidepressants : Consensus guidelines for evaluating quantitative reviews of antidepressant efficacy. In: Neuropsychopharmacology. 2005 ; Vol. 30, No. 3. pp. 445-460.
@article{2e1dec56fffe484ba27a6b8dc86aee96,
title = "Comparing the effects of antidepressants: Consensus guidelines for evaluating quantitative reviews of antidepressant efficacy",
abstract = "With increasing numbers of treatment options available for patients with major depression over the last decade and the growing body of evidence describing their efficacy and safety, clinicians often find it difficult to determine the best and most appropriate evidence-based treatment for each patient. Systematic reviews utilizing statistical methods that synthesize and evaluate data from a number of studies have become increasingly more available over the past decade. We review major findings and lessons learned from salient examples of quantitative analyses of antidepressant research and provide recommendations for meta-analysts, journal and grant reviewers, and research 'consumers' (ie, clinicians) for conducting, reporting, and evaluating such analyses.",
keywords = "Antidepressive agents, Evidence-based medicine, Meta-analysis, Quality control, Randomized controlled trials, Research design",
author = "Lieberman, {Jeffery A.} and Joel Greenhouse and Hamer, {Robert M.} and Krishnan, {K. Ranga} and Charles Nemeroff and Sheehan, {David V.} and Thase, {Michael E.} and Keller, {Martin B.}",
year = "2005",
month = "3",
day = "1",
doi = "10.1038/sj.npp.1300571",
language = "English",
volume = "30",
pages = "445--460",
journal = "Neuropsychopharmacology",
issn = "0893-133X",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Comparing the effects of antidepressants

T2 - Consensus guidelines for evaluating quantitative reviews of antidepressant efficacy

AU - Lieberman, Jeffery A.

AU - Greenhouse, Joel

AU - Hamer, Robert M.

AU - Krishnan, K. Ranga

AU - Nemeroff, Charles

AU - Sheehan, David V.

AU - Thase, Michael E.

AU - Keller, Martin B.

PY - 2005/3/1

Y1 - 2005/3/1

N2 - With increasing numbers of treatment options available for patients with major depression over the last decade and the growing body of evidence describing their efficacy and safety, clinicians often find it difficult to determine the best and most appropriate evidence-based treatment for each patient. Systematic reviews utilizing statistical methods that synthesize and evaluate data from a number of studies have become increasingly more available over the past decade. We review major findings and lessons learned from salient examples of quantitative analyses of antidepressant research and provide recommendations for meta-analysts, journal and grant reviewers, and research 'consumers' (ie, clinicians) for conducting, reporting, and evaluating such analyses.

AB - With increasing numbers of treatment options available for patients with major depression over the last decade and the growing body of evidence describing their efficacy and safety, clinicians often find it difficult to determine the best and most appropriate evidence-based treatment for each patient. Systematic reviews utilizing statistical methods that synthesize and evaluate data from a number of studies have become increasingly more available over the past decade. We review major findings and lessons learned from salient examples of quantitative analyses of antidepressant research and provide recommendations for meta-analysts, journal and grant reviewers, and research 'consumers' (ie, clinicians) for conducting, reporting, and evaluating such analyses.

KW - Antidepressive agents

KW - Evidence-based medicine

KW - Meta-analysis

KW - Quality control

KW - Randomized controlled trials

KW - Research design

UR - http://www.scopus.com/inward/record.url?scp=13944265657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13944265657&partnerID=8YFLogxK

U2 - 10.1038/sj.npp.1300571

DO - 10.1038/sj.npp.1300571

M3 - Article

C2 - 15647752

AN - SCOPUS:13944265657

VL - 30

SP - 445

EP - 460

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

SN - 0893-133X

IS - 3

ER -